TY - JOUR
T1 - The Use of Contrast Agents in Interventional Pain Procedures
T2 - A Multispecialty and Multisociety Practice Advisory on Nephrogenic Systemic Fibrosis, Gadolinium Deposition in the Brain, Encephalopathy after Unintentional Intrathecal Gadolinium Injection, and Hypersensitivity Reactions
AU - Benzon, Honorio T.
AU - Maus, Timothy P.
AU - Kang, Hye Ryun
AU - Provenzano, David A.
AU - Bhatia, Anuj
AU - Diehn, Felix
AU - Nelson, Ariana
AU - McCormick, Zachary L.
AU - Liu, Benjamin P.
AU - De Andres Ares, Javier
AU - Anitescu, Magdalena
AU - Blackham, Kristine
AU - Bhaskar, Arun
AU - Brill, Silviu
AU - Collins, Jeremy
AU - Gulve, Ashish
AU - Hurley, Robert W.
AU - Jeon, Young Hoon
AU - Moon, Jee Youn
AU - Rauck, Richard L.
AU - Rodes, Meghan
AU - Lee, Ryan K.
AU - Shah, Vinil
AU - Shanthanna, Harsha
AU - Van Zundert, Jan
AU - Huntoon, Marc
AU - Rathmell, James P.
AU - Borges, Mario Sanchez
AU - Cohen, Steven P.
AU - Greenberger, Paul A.
N1 - Publisher Copyright:
© 2021 Lippincott Williams and Wilkins. All rights reserved.
PY - 2021/8/1
Y1 - 2021/8/1
N2 - This Practice Advisory presents a comprehensive and evidence-based set of position statements and recommendations for the use of contrast media in interventional pain procedures. The advisory was established by an international panel of experts under the auspices of 11 multinational and multispecialty organizations based on a comprehensive review of the literature up to December 31, 2019. The advisory discusses the risks of using gadolinium-based contrast agents. These include nephrogenic systemic fibrosis, gadolinium brain deposition/retention, and encephalopathy and death after an unintentional intrathecal gadolinium injection. The advisory provides recommendations on the selection of a specific gadolinium-based contrast agent in patients with renal insufficiency, those who had multiple gadolinium-enhanced magnetic resonance imaging examinations, and in cases of paraspinal injections. Additionally, recommendations are made for patients who have a history of mild, moderate, or severe hypersensitivity reactions to contrast medium.
AB - This Practice Advisory presents a comprehensive and evidence-based set of position statements and recommendations for the use of contrast media in interventional pain procedures. The advisory was established by an international panel of experts under the auspices of 11 multinational and multispecialty organizations based on a comprehensive review of the literature up to December 31, 2019. The advisory discusses the risks of using gadolinium-based contrast agents. These include nephrogenic systemic fibrosis, gadolinium brain deposition/retention, and encephalopathy and death after an unintentional intrathecal gadolinium injection. The advisory provides recommendations on the selection of a specific gadolinium-based contrast agent in patients with renal insufficiency, those who had multiple gadolinium-enhanced magnetic resonance imaging examinations, and in cases of paraspinal injections. Additionally, recommendations are made for patients who have a history of mild, moderate, or severe hypersensitivity reactions to contrast medium.
UR - http://www.scopus.com/inward/record.url?scp=85109709234&partnerID=8YFLogxK
U2 - 10.1213/ANE.0000000000005443
DO - 10.1213/ANE.0000000000005443
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 33755647
AN - SCOPUS:85109709234
SN - 0003-2999
VL - 133
SP - 535
EP - 552
JO - Anesthesia and Analgesia
JF - Anesthesia and Analgesia
IS - 2
ER -
